David Kram MD (He/Him)
Pediatric Neuro-Oncology
Physician
Join to View Full Profile
101 Manning DrChapel Hill, NC 27514
Phone+1 984-974-1000
Fax+1 919-966-7629
Dr. Kram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Kram is a pediatric hematologist/oncologist in Chapel Hill, NC.
Education & Training
Oregon Health & Science UniversityMCR, Clinical Research, 2014 - 2016
Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Hematology/Oncology, 2013 - 2016
University of ConnecticutResidency, Pediatrics, 2010 - 2013
Tel Aviv University SacklerClass of 2010
Certifications & Licensure
OR State Medical License 2013 - Present
NC State Medical License 2016 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Membership Alpha Omega Alpha, 2018
Clinical Trials
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2018 Apr 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient Glioblastoma.Humeyra Kaanoglu, Adebimpe Adefolaju, Casey Fraley, Mariah Shobande, Rajaneekar Dasari
Molecular Cancer Therapeutics. 2025-03-25 - Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine.Breanna Mann, Nichole Artz, Rami Darawsheh, David E Kram, Shawn Hingtgen
NPJ Precision Oncology. 2025-02-14 - 2 citationsA Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.James F Haberberger, Worthy Pegram, Nicholas Britt, Kelsie Schiavone, Eric Severson
The Oncologist. 2024-01-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
